OSR Health Board Authorizes Management to Engage with Potential Acquirer of OSRK for Reverse Takeover

What happened

OSR Health’s board authorized management to pursue a proposed sale of its controlling interest in OSRK to an undisclosed Nasdaq-listed company for a potential reverse takeover. The proposed stock-for-stock exchange would make OSR Health the controlling shareholder of the resulting company, which would own all of OSRK; the deal is not final.

Proposed

Global impact / market context

OSRK is OSR Health’s principal operating subsidiary, with biotechnology and healthcare businesses. If completed, the proposed share exchange could change how OSR Health holds that portfolio and give it control of the Nasdaq-listed combined company. The company says the transaction is intended to unlock portfolio value.

Analyst inference

OSR Health describes the potential reverse takeover as a key part of its plan to return its portfolio to a national exchange, while also pursuing an OTCQB uplisting, a move to a higher OTC market tier. Neither route is described as completed in the supplied text.

Confirmed

What to watch

1. Watch for a definitive transaction announcement and required approvals; the board has only authorized management to pursue a sale, and the potential buyer remains undisclosed. Analyst inference
2. Check whether the proposed stock-for-stock exchange proceeds and how its terms define OSR Health’s control of the new company and that company’s ownership of all OSRK. Analyst inference
3. The company says the contemplated transaction value, including a proposed earn-out for OSR Health, would exceed the valuation applied when it acquired OSRK in February 2025. Confirmed

Evidence

• accessnewswire.com